Lanean...
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
BACKGROUND: The fibroblast growth factor receptor (FGFR) signaling pathway is activated in multiple tumor types through gene amplifications, single base substitutions, or gene fusions. Multiple small molecule kinase inhibitors targeting FGFR are currently being evaluated in clinical trials for patie...
Gorde:
| Argitaratua izan da: | Prostate Cancer Prostatic Dis |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824932/ https://ncbi.nlm.nih.gov/pubmed/31043681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41391-019-0145-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|